Addition of neurons to cultures of non-neuronal cells derived from quail embryonic dorsal root ganglia causes a 2.5fold increase in the proportion of cells that express the glial marker Schwann cell myelin protein (SMP) when compared to cultures devoid of neurons. This effect is mediated by BDNF because incubation with a trkB immunoadhesin that sequesters BDNF, but not with trkA or trkC immunoadhesins, abolishes this stimulation. This neuronal activity can be mimicked by treatment with soluble BDNF that stimulates specifically the conversion of SMP-negative glial cells into cells that express this phenotype. That BDNF is the endogenous neuronderived factor affecting glial development is further supported by the observation that BDNF is extensively expressed in developing sensory neurons of the avian ganglia both in vivo and in vitro, but not by the satellite cells. These results show for the first time a paracrine role for neuronal BDNF on differentiation of peripheral glial cells. This effect of BDNF is likely to be mediated by the ~75 neurotrophin receptor because: (1) ~75 immunoreactive protein is expressed by a subset of satellite cells; (2) neutralization of p75 abolishes the BDNI-induced stimulation; (3) a treatment of non-neuronal cell cultures with equimolar concentrations of either soluble NGF or NT-3 also affects the proportion of cells that become SMP-positive. Whereas NGF stimulates the acquisition of this glial antigen to a similar extent as BDNF, NT-3 inhibits its expression, suggesting that distinct neurotrophins signal differentially through ~75. These findings also suggest that the definitive phenotype of peripheral glia is determined by a balance between positive and inhibitory signals arising in adjacent neurons. 0 1997 Elsevier Science Ireland Ltd. All rights reserved
Introduction
The nascent dorsal root ganglia (DRG) are initially colonized by heterogeneous subsets of neural crest progenitors displaying different developmental potentials. Lineage analysis of the neural crest has shown that some sensory neurons as well as glial cells differentiate from subsets of committed progenitors, but most of them derive from multipotent precursors (Baroffio et al., 1991; Bronner-Fraser and Fraser, 1988; Sieber-Blum, 1989; Dupin et al., 1990) . Although a progressive restriction in the developmental capacity of cells occurs upon gangliogenesis, some multipotent progenitors can still be found in the young ganglia (Duff et al., 1991; Le Douarin et al., 1991; Sextier-Sainte Claire Deville et al., 1992) .
These findings raise the question of the mechanisms leading to phenotypic diversification of distinct progenitors into neurons and glia within the apparently homogeneous milieu of a nascent ganglion. A possible clue to approach this issue resides in the observation that the differentiation of neurons and glia follows an ordered sequence. Neuronal differentiation in sensory ganglia precedes that of the glia. Moreover, different aspects of glial cell differentiation were shown to be modulated by interactions with neurons, suggesting that this temporal sequence of events has also functional implications (Pannese et al., 1972; Pannese et al., 1975; Aguayo et al., 1976; Bunge et al., 1980; Salzer et al., 1980a; Salzer et al., 1980b; Bray et al., 1981; Holton and Weston, 1982a; Hol-hf. Prugirtin-Bluger et al. /Mechanisms of Development 61 (1997) 99-1 I1 ton and Weston, 1982b; Lemke and Chao, 1988; Ratner et al., 1988; Jessen et al., 1990; Rude1 and Rohrer, 1992) . The identity of neuronal signalling molecules involved in the control of glial differentiation are largely unknown. Either soluble factors, contact-dependent mechanisms, or both, could be envisaged to mediate paracrine interactions between neurons and surrounding glial cells within peripheral ganglia (Holton and Weston, 1982a; Holton and Weston, 1982b; Rude1 and Rohrer, 1992) . Furthermore, a close interaction with neurons is necessary for the development of Schwann cell progenitors. One factor that mediates these interactions is glial growth factor-2 (GGF2). a secreted form of GGF that is present in cultured neuronal cells from dissociated peripheral ganglia and that stimulates the Schwann cells to divide (Marchionni et al., 1993; Shah et al., 1994) . Another factor present in the early neural tube and in DRG neurons is basic FGF (Kalcheim and Neufeld, 1990 ) that was found in early embryos to promote the survival of neural crest-derived non-neuronal cells (Kalcheim, 1989) and at later stages to act on Schwann cell progenitors isolated from peripheral nerves of young rat embryos (Jessen et al., 1994) .
Another family of growth factors with potential relevance for glial development are the neurotrophins.
The neurotrophins display a variety of actions on neurons and their progenitors (Davies, 1994; Kalcheim. 1996a; Kalcheim, 1996b) . As such, they are synthesized in the target fields innervated by peripheral neurons and can reach the neurons in the ganglia by transport from their targets (DiStefano et al., 1992) . More recently, in situ hybridization revealed that BDNF and NT3 mRNAs are also synthesized within rodent DRG (Ernfors et al., 1990; Ernfors and Persson, 1991; Schecterson and Bothwell, 1992) . Moreover, BDNF is produced in chicken DRG from E4.5, as suggested by PCR studies (Wright et al., 1992) . These observations suggest that neurotrophins may also have local roles within the ganglionic environment to promote either neuronal or glial development.
The biological actions of the neurotrophins are mediated by the trk family of tyrosine kinase receptors (reviewed by Barbacid, 1994) . In particular, BDNF binds to the trkB receptor whose full length form is able to transduce a biological signal. Splice variants lacking the tyrosine kinase domain have also been detected (Klein et al., 1990; Middlemas et al., 1991) . These truncated forms have been shown to be expressed in a variety of non-neuronal cells (Klein et al., 1990; Frisen et al., 1993; Funakoshi et al., 1993; Biffo et al., 1995) . Recently, it was suggested that the truncated form of the t&B receptor present on non-neuronal cells of chick embryos mediates the internalization of BDNF, a process that restricts its availability (Biffo et al., 1995) .
Neurotrophins also bind with lower affinity (kd = IO-" M) to the p75 receptor (reviewed by Chao, 1994) . The role of p75 in high affinity binding of neurotrophins is still controversial. Although the trk receptors can work alone (Klein et al., 1991; Radeke and Feinstein, 1991; Holtzman et al., 1992) , the p75 receptor was shown to modulate in some cells either the binding of neurotrophins to the trk receptors (Hempstead et al., 1991; Verge et al., 1992) , or the trk signal transduction (Barker and Shooter, 1994; Hantzopoulos et al., 1994; Lee et al., 1994; Verdi et al.. 1994) . In addition, p75 may also have functions independent of the trk receptors (Lee et al., 1992; Rabizadeh et al., 1993; Barrett and Bartlett, 1994; Dubrowsky et al., 1994) .
The p75 receptor is widely expressed in distinct embryonic sites (Emfors et al., 1988; Heuer et al., 1990; Bothwell, 1991) , including peripheral glia (Zimmermann and Sutter, 1983; Rohrer, 1985; Johnson et al., 1988; Anton and Matthew, 1992) . During ganglion development in the chick embryo (E6-lo), the percentage of glial cells expressing the low affinity NGF receptors is high and was shown to decrease afterwards, suggesting that the low affinity receptor might play a role in glial maturation.
In the present study, we have further addressed the dependence of glial development upon neuronal signalling. We have focused on the modulation of the express ion of the Schwann cell myelin protein (SMP) antigen (Dulac et al., 1988; Dulac et al., 1992) , a marker present on all avian peripheral glial lineages in vitro, that include myelinating and non-myelinating Schwann cells, ganglionit satellite cells and enteric glia (reviewed in Le Douarin and Ziller, 1993) . We report that the proportion of satellite cells that express SMP is upregulated by the neurons, and that neuronal stimulation is mediated by endogenous BDNF, but not by NT-3 or NGF. In addition, we provide evidence that the p75 receptor is involved in mediating the effect of BDNF on the conversion of SMP-to SMP+ glial cells in DRG cultures.
Results

Neurons stimulate an increase in the proportion of SUP-immunoreactive gtial cells in cultures of DRG nonneuronal cells
Cultures of non-neuronal cells were stained with anti-SMP 20 h after seeding. Expression of the SMP antigen was observed on glial cells with heterogeneous morphologies. Some cells had an elongated, fusiform aspect characteristic of Schwann cells, whereas others had flat and polymorphic appearance (Fig. 1A) . In cultures grown in the absence of neurons, the proportion of non-neuronal cells that expressed the SMP antigen was 10.4 + 2.7% of the total cells and this value was highly consistent among different experiments (Fig. 2 , first bar, and see also Figs. 6 and 7). Addition of a neuronal suspension to non-neuronal cell cultures resulted, after overnight incubation, in a 2.5-fold stimulation in the percentage of glial cells expressing the SMP antigen over control values (26 + 3.1% of the total satellite cells present; Fig. 2 , second bar, P < 0.004). This stimulation index was also found to be con-from E6 it became more localized to the lateroventral aspect of the DRG (not shown). Furthermore, the intensity of the BDNF signal progressively increased towards E7 and E8 (Fig. 3A,B. ). At these stages, more neurons were positive for BDNF mRNA in limb-innervating DRG than in non limb-innervating ganglia (not shown). In contrast, the expression of NT-3 mRNA was undetectable until E 6-7 when a few neurons per DRG, preferentially localized Whereas the total number of cells present in the cultures increased from 1760 f 30 to 2300 + 150 cells/60 fields upon addition of the neuronal suspensions (Fig. 2B) , the number of nonneuronal cells did not significantly change (not shown). These results show that neurons upregulate the expression of the SMP antigen in glial cells. In the neuron-containing cultures, however, physical contact with the neuronal bodies or the neurites was not found to be an absolute requirement for SMP expression by the glial cells, as SMP staining was also observed in cells located in the vicinity, but not in direct contact with neurons, suggesting that a soluble factor(s) mediates this stimulation.
BDNF is expressed by DRG neurons in vivo and in culture
We have studied the expression of BDNF in quail and chicken embryonic DRG by in situ hybridization with a chicken-specific probe. BDNF mRNA signal was detected in all ganglia along the axis from E5 onward. Expression pattern on E5 was widespread throughout the ganglia and in its lateroventral part, were observed to express NT-3 signal (Fig. 3C,D) .
Cultured neuronal cells were also found to express BDNF. Fig. 4A ,B illustrates the expression of BDNFimmunoreactive protein in neurons cultured from E8 lumbosacral DRG. The staining was cytoplasmic and was confined to the neuronal cell bodies. No immunolabeling of satellite cells could be seen. The specificity of antibody staining was assessed by incubation with a guinea pig preimmune serum or by preadsorption with excess BDNF which gave only background staining ( Fig. 4C .D). These observations prompted us to test the hypothesis that neuronal stimulation in the proportion of SMP-positive glia is mediated by BDNF.
Neuron-derived BDNF stimulates an increase in the proportion of SMP-positive satellite cells
Suspensions of enriched neurons were preincubated for 30 min with 500 ng/ml of trkB immunoadhesins and then added to cultures of non-neuronal cells for an additional 20 h. Treatment with trkB fusion proteins resulted in a significant decrease in the proportion of SMP-positive satellite cells when compared with the levels obtained after neuronal addition to the glial cells (P < 0.005), and almost back to a level found in glial cultures devoid of neurons (Fig. 2) . Furthermore, this decrease, observed upon t&B immunoadhesin treatment, was completely prevented when exogenous recombinant BDNF (50 ng/ml) was simultaneously present in the cocultures (P < 0.005; Fig. 2 , compare the third and fourth bars).
To further examine whether the stimulatory effect of the neurons on the proportion of satellite cells expressing SMP is specifically mediated by BDNF, dissociated cultures of DRG cells (mixed neurons and glia) were established and incubated in the presence of either t&B, trkA or trkC immunoadhesins for 20 h. The t&B fusion proteins caused a significant decrease in the proportion of SMP+ glial cells when compared to the untreated controls (32 * 2.4 and 56 + 3.7%, respectively, P < 0.002; Fig. 5A ). In striking contrast, treatment with either trkC or trkA fusion proteins at a concentration of 500 ng/ml (Fig. 5A ) or with higher concentrations (2000 @ml, data not shown) was without effect. plane of the DRG, characteristic of a neuronal expression pattern. In contrast, very few DRG neurons express NT-3 mRNA (arrowheads in C), despite the intense signal observed over motoneurons (M) (see also Kahane et al., 1996) . v, vertebra. Bar = 70 pm. It is worth mentioning that ihe proportion of SMP+ glial cells of the total non-neuronal cells was higher in the control mixed cultures that were directly established from dissociated DRG (55%, Fig. 5 ) when compared to cultures in which neurons were reassociated with non-neuronal cells (26%, Fig. 2 ). In line with these observations, the proportion of neurons to total cells in the mixed cultures was two-fold higher than that in the reassociated ones (23% compared to 13%, respectively), indicating that the proportion of glial cells expressing SMP increases with increasing neuronal numbers. Nevertheless, the possibility cannot be excluded that the procedure employed to obtain pure non-neuronal cells reduces the proportion of BDNFresponsive glial cells.
In all the treatments described above, the trk immunoadhesins employed had no measurable effect on the total number of neurons or glia (Fig. 5B , and see also BDNF regulates phenotypic expression in adjacent glia, but is not involved in controlling cell number at the embryonic ages examined.
Soluble BDNF stimulates the generation of SMPpositive glial cells without affecting their survival or proliferation
We have provided evidence that the neuronal stimulation of the proportion of SMP+ glial cells is mediated by BDNF in mixed cultures containing both neurons and nonneuronal cells. To directly test the effects of exogenous BDNF on glial cells, homogeneous cultures of satellite cells were prepared and incubated in the presence of purified recombinant BDNF. As shown in Fig. 6 , the addition of 50 ng/ml BDNF caused a two-fold stimulation in the proportion of SMP+ satellite cells when compared to cultures devoid of factor. A significant 1.6-fold stimulation was already obtained with 10 ng/ml of BDNF (Fig. 7) , but lower factor concentrations were without effect. Treatment with either concentration of BDNF did not significantly affect the number of total cells (data not shown), suggesting that this factor has no survival activity on the glial cells.
To examine whether the stimulation in the proportion of SMP+ glial cells induced by BDNF results from enhanced proliferation of the SMP+ population, glial cultures were pulsed with radiolabeled thymidine for a 5 h period followed by fixation, SMP immunolabeling and autoradiography. In spite of a 1.6-fold stimulation in the proportion of cells expressing the SMP antigen in the presence of BDNF (10 ng/ml), the proportion of SMP+ cells with thymidine grains was very low and not significantly different (1.3 f 0.7% and 1.6 f 0.68% in control versus BDNF-treated, respectively). BDNF had no mitogenic effect either on the SMP-negative non-neuronal population because the percentage of total cell nuclei containing thymidine remained unchanged upon factor treatment (18.1 + 2.2% compared to 14.5 + 2.0% in control and BDNF-treated cells, respectively). Interestingly, the per-
Control
Anti-p75 BDNF Anti-p'lB+BDNF centage of cycling satellite cells among the SMP+ population was much lower than that of the SMP-cells, suggesting that upregulation of SMP expression may be correlated with a withdrawal from the cell cycle.
Altogether, these results suggest that neuronal factors such as BDNF positively regulate a phenotypic shift in glial cells from an SMP-to an SMP+ state without affecting either their survival or their proliferation.
p75 mediates the activity of BDNF on glial cells
The possibility was tested that the BDNF-mediated effect is modulated by ~75. To this end, we asked whether neutralization of ~75 in living cells would affect the BDNF-induced increase in the proportion of satellite cells expressing SMP. Cultures containing only non-neuronal cells were first treated for 1 h with (or without) anti-~75 antibodies (1:200) directed to the extracellular domain of the protein, followed by addition of 50 ng/ml of BDNF (or no factor). As shown in Fig. 6 , a two-fold stimulation in the percentage of SMP-expressing cells was obtained in the presence of BDNF when compared to control values without added factor (P < 0.002, third and first bars). Treatment with antibodies to ~75 had no effect on the basal level of SMP expression; however, they almost completely prevented the increase in the proportion of SMPimmunoreactive glial cells otherwise obtained upon treatment with BDNF (P < 0.004, compare fourth and third bars). A lower but significant reduction in the BDNFinduced effect could even be detected with a 1:400 dilution of ~75 antibody (not shown). None of the mentioned concentrations of antibody had any effect on the total number of non-neuronal cells, in further support of a role for BDNF and ~75 on regulation of SMP expression but not on cell number.
Because, in contrast to the trk receptors, ~75 binds all neurotrophins with similar affinity, the possibility was tested that addition of exogenous NGF or NT-3 to cultures of enriched non-neuronal cells could mimic, at a similar concentration, the activity of BDNF on SMP expression, even if these are not likely to be the endogenous factors that mediate the neuronal effect (see Fig. 5 ). Indeed, significant 60% and 55% stimulations in the percentage of SMP-immunoreactive glial cells were obtained upon treatment with either BDNF or NGF at subsaturating concentrations (10 "g/ml), respectively (P < 0.005, Fig. 7) . Surprisingly, addition of soluble NT-3 (10 ng/ml) had the opposite effect, reducing by half the proportion of SMP+ cells observed in control cultures (P < 0.004). This effect of NT-3 was not accompanied by any visible signs of cell death among Hoechst-stained cultures, or any change in the total number of non-neuronal cells when compared with control cultures and cultures treated with BDNF or NGF (Fig. 7 and data not shown) . Interestingly, combined treatment with both BDNF and NT-3 gave an average value between that observed for each factor separately (Fig. 7, fifth bar) , indicative of an equipotent ability of the two factors to compete for binding and signalling through the same receptor, albeit leading to opposite biological actions. In line with such an interpretation, the inhibitory effect of NT-3 on the expression of the SMP marker was found to be prevented by treatment of the cultures with anti-p75. In two separate experiments, NT-3 caused a two-fold reduction in the proportion of SMP+ glial cells (8 + 0.4% compared to 16.4 + 2.3% in NT-3-treated compared to controls), whereas the combined treatment with both NT-3 and anti-p75 yielded an SMP value not significantly different from that obtained in control untreated cultures (14.0 + 2.6%). These results suggest that the expression of SMP in DRG glia is positively regulated by BDNF and negatively regulated by NT-3, and that the ~75 receptor mediates both types of signals.
To further substantiate a possible role for the glial ~75 receptors, we examined the relationship between the expression of SMP and ~75 proteins on glial cells in lday-old mixed DRG cultures. More than 60% of the SMP+ (Fig. 8) . In addition, p75+/SMP-glial cells were also apparent in the doubleimmunolabeled cultures (compare Fig. 8E arrows with D) whereas all neurons observed were p75+/SMP-. Taken together, these results suggest that ~75 receptors are involved in mediating the BDNF-induced stimulation of SMP expression in satellite cells.
Discussion
In this study we present direct evidence that DRG neurons stimulate an increase in the proportion of glial cells that express the SMP antigen, an early marker of glial development.
Moreover, we find that this short range effect is mediated by neuron-derived BDNF. Finally, our results indicate that BDNF may exert this activity through the low affinity p75 receptor present on the responsive glial cells.
The acquisition of the SMP+ phenotype was proposed to be part of a cell-autonomous pathway of differentiation common to all peripheral nervous system glial lineages because this marker is expressed in vitro by all types of peripheral glia (Le Douarin and Ziller, 1993) . Nevertheless, the expression of SMP is tightly regulated by environmental cues. For instance, the microenvironments of the DRG and the gut were shown to repress the transcription of the SMP gene CameronCurry et al., 1993) . In striking contrast, activation of the SMP marker was observed upon dissociation of DRG into single cells (Cameron-Curry et al., 1993) . These findings suggest that the definitive phenotype of peripheral glia is determined by a balance between positive and inhibitory signals derived from adjacent neurons. Here we provide evidence that an in vitro system can be extremely useful for identifying such signals. We show that neuron-derived BDNF positively regulates the expression of the SMP phenotype. In contrast, NT-3, poorly synthesized in avian DRG, but present there at the protein level (Pinto et al., 1993) most likely due to retrograde transport from the targets, inhibits SMP expression. Thus, a distinctive interplay between BDNF and NT-3-like signals in vivo could account for the observed expression of SMP in Schwann cells and the absence of detectable SMP gene expression in satellite ganglionic cells, a notion that awaits further testing.
The upregulation of the SMP marker by BDNF does not result from increased proliferation or survival of the glial cells. We therefore interpret this effect as a phenotypic shift in individual SMP-negative cells to acquire the SMP protein. The SMP-negative cells induced to express the SMP marker by BDNF may be immature Schwann cells normally present in DRG, ganglionic satellite cells that transdifferentiate into a Schwann cell-like phenotype in culture, and/or a subset of progenitors present in E8 DRG that retains the potential to become SMP+ as part of its developmental program. The lack of distinctive markers besides SMP, that recognize each of the above avian cell subpopulations at the earliest stages of gliogenesis (see Le Douarin et al., 1991 and Ziller, 1993) , makes it difficult at present to further characterize the cells induced by BDNF to express SMP.
Several lines of evidence support the notion that BDNF mediates the paracrine effect of the neurons on the expression of SMP by glial cells. First, incubation with t&B immunoadhesins that specifically sequester the BDNF produced by the cultured neurons abolishes this stimulation. Second, this effect can be completely prevented if the cultures are supplemented with excess BDNF. Third, neither trkC nor trkA immunoadhesins that selectively bind to NT-3 and NGF, respectively, have an effect on the proportion of glial cells that acquire the SMP marker. Fourth, soluble BDNF mimics the effect of the neurons on the expression of SMP when added upon purified glial cells. These results are in good correlation with the finding that BDNF is the only neurotrophin largely synthesized and expressed in avian DRG neurons, whereas NT3 mRNA is found only in a small number of limb-innervating neurons and NGF is not synthesized at all in the ganglia (unpublished observations and see Schecterson and Bothwell, 1992) .
The use of antisense strategies has shown that BDNF acts by an autocrine mechanism as well at early stages of ganglion development to affect the maturation of sensory neuroblasts (Wright et al., 1992) , and at adulthood to mediate neuronal survival (Acheson et al., 1995) . In another study, it has been found that NGF upregulates the expression of the Ll cell adhesion molecule in early postnatal mouse Schwann cells. This effect can also be accounted for by local interactions and even by an autocrine mechanism; Schwann cells are known to produce NGF, and treatment of Schwann cells with antibodies against NGF abolishes the effect observed (Seilheimer and Schachner, 1987) . In the present system, the possibility exists that neuronal BDNF acts upon glial cells to stimulate in turn an autocrine loop mediated by NGF or by other glial-specific molecules.
In fact. treatment with soluble NGF mimics the BDNF effect on SMP expression. In any of the above cases, growing evidence substantiates the notion that in addition to being target-derived factors, the neurotrophins act in a compartmentalized manner near their sites of synthesis to influence both neural and non-neural cells (Sri11 et al., 1995; Acheson and Lindsay, 1996; Kalcheim, 1996a; Kalcheim, 1996b ; and the present study).
BDNF might exert its biological activities on glial cells through the trkB receptor, through the low affinity p75 receptor, or via a combined activity of both receptor types. We have examined whether the effect of BDNF on DRG glia is mediated by ~75. Three lines of evidence support this possibility. First, target DRG satellite cells express p75 immunoreactivity.
Interestingly, more than 60% of the SMP+ cells are also p75-t in 1 day cultures of total DRG cells, meaning that the remaining SMP+ cells are p75-, and we have also observed p75+/SMP-nonneuronal cells. What is the significance of these proportions in terms of the possible activity of BDNF through this receptor? Previous studies have reported that the expression of low affinity NGF receptors on glial cells is developmentally regulated, meaning that cells whose differentiation is already well underway down-regulate receptor expression (Zimmermann and Sutter, 1983; Rohrer, 1985; Johnson et al., 1988) . The SMP+/p75-satellite cells might therefore belong to a category that was initially p75+. Conversely, the p75+/SM-cells may be still undifferentiated satellite cells or even glial progenitors which have not yet acquired the SMP phenotype, but are potentially able to respond to a neuronal signal via ~75.
The second argument in support of a mediation by p75 of BDNF activity stems from inhibition experiments with anti-p75 antibodies. Antibodies directed against the extracellular portion of the molecule prevented the stimulation of SMP expression induced by soluble BDNF in cultures of homogeneous glial cells. In fact, classical binding studies of iodinated NGF to cultured DRG satellite cells revealed that glial cells bind the ligand only with low affinity (characteristic of the ~75 receptor) in contrast to neurons which reveal NGF binding with both high and low affinities (trk versus ~75, respectively) (Zimmermann and Sutter, 1983) . More recently, it was reported that some types of non-neuronal cells express a truncated form of trkB that is devoid of the cytoplasmic domain of the protein (Biffo et al., 1995) . Satellite cells of the avian DRG revealed, however, no expression of this form of trkB, either because they are absent from these cells, as predicted by the binding studies, or because their level of expression is below the sensitivity of the hybridization procedure employed (Stefano Biffo, personal communication) . A definitive proof whether the effect of BDNF on glia is transduced exclusively by the ~75 receptor or by some combination between a truncated form of trkB and ~75 awaits detection of a trkB signal in satellite cell cultures by more sensitive methods such as RT-PCR. In this context, it was recently found that in perinatal Schwann cells, NGF signals through ~75 only because these cells lack trkA mRNA (Carter et al., 1996) .
A third argument in support of an effect of BDNF through ~75 is that its effect could be mimicked by similar concentrations of NGF, consistent with the finding that ~75 binds all neurotrophins with similar affinities. To our surprise, similar concentrations of NT-3 caused a reduction in the proportion of cells expressing SMP, and treatment with both BDNF and NT-3 led to intermediate values, suggesting that the two neurotrophins compete for binding to the same receptor and compensate each other's effects. These results show that distinct neurotrophins may give different responses through ~75. In further support of this action, only NGF proved capable of activating the transcription factor NF-kB by signalling through ~75 in Schwann cells. Neither BDNF nor NT-3 showed any stimulation (Carter et al., 1996) .
Taken together, these results reflect the variety and complexity of actions potentially mediated by the low affinity ~75 receptor, which are likely to differ according to basic parameters of the cellular context such as cell type and degree of cell commitment.
Experimental procedures
Cultures of dissociated DRG cells and enrichment of non-neuronal cells
DRG were dissected from the lumbosacral level of the axis of 8-day-old (E8) quail embryos (Coturnix coturnix Japonica), freed of non-ganglionic tissue and collected in ice-cold phosphate-buffered saline (PBS; pH 7.3). For preparation of dissociated cell suspensions, the ganglia were transferred to Ca'+, Mg'+-free PBS containing 0.05% trypsin and 0.002% DNase for IO-15 min at 37°C. Single cells were obtained by gentle trituration with a firepolished micropipette (tip opening 30-50 pm). Cells were resuspended in serum-free SFRI medium (Berganton, France) and the equivalent of two ganglia was plated in 100 ~1 in 12 mm diameter circles made in the center of 35 mm wells. Culture wells were precoated with fibronectin (50 pg/ml). Cells were allowed to adhere to the substrate for 2 h and only then purified recombinant factors, fusion proteins or antibodies were added.
To separate neurons from non-neuronal cells, the dissociated cells were allowed to adhere to the substrate for l-1.5 h. Each dish was then transferred to the inverted microscope and flushed several times with mild currents of cold PBS while continuously monitoring the procedure by close microscopic examination, until all visible cells with neuronal morphology were eliminated. This procedure yielded highly enriched cultures of non-neuronal cells with a number of neurons not exceeding 3-5% of the initial neuronal cells. When necessary, the neurons flushed from the required number of cultures were pooled in cold PBS, resuspended in SFRI medium and added on top of nonneuronal cell cultures.
Neurotrophins, Trk-IgG fusion molecules, and ~7.5 antibodies
Purified human recombinant neurotrophins (BDNF, NT-3 and NGF) were from Genentech, Inc.. Antibodies to ~75 were a generous gift of Moses Chao. Two rabbit polyclonal antisera were used; the first (9651) was raised against the extracellular domain (amino acids 43-161) of mouse ~75 as a GST-2T fusion protein (Huber and Chao, 1995) . The second antibody (9992) was directed to the entire cytoplasmic domain of human ~75 (amino acids 250-399), and was prepared as a pGEX-2T fusion protein (Chittka and Chao, 1995) . Both antibodies were found to cross-react with avian species.
The trk fusion proteins are soluble molecules that mimic intact trk receptors in their binding specificity and affinity, and act by sequestering their cognate neurotrophins, thus inhibiting their biological activities. Briefly, sequences encoding the extracellular domains of the human trks were fused in frame with sequences encoding the Fc domain of human IgG heavy chain as already described (McMahon et al., 1995; Shelton et al., 1995) . The resulting chimeras contain two trk extracellular domains linked via the association of the IgG Fc regions. All human chimeric trks showed specific high affinity binding to their expected neurotrophins, and were demonstrated to block selectively the biological activity of their cognate ligands in a survival assay of avian DRG neurons and in a neurite outgrowth assay from explanted DRG. One pg of each type of immunoadhesin was found to completely block neuronal survi-val and neurite outgrowth induced by up to 10 @ml of the respective neurotrophin  Kahane and Kalcheim, data not shown).
[3H]Thymidine incorporation and autoradiography
One-day-old control and BDNF-treated cultures of nonneuronal cells were labeled for an additional 5 h with 0.5 $X/ml [methyl-3H]thymidine (40-60 Ci/mmol; Amersham). At the end of incubation, dishes were fixed in 4% formaldehyde, stained with the SMP antibody (see below) and processed for autoradiography as previously described (Kalcheim et al., 1992) .
Immunolabeling
Subsets of non-neuronal cells were stained with the SMP monoclonal antibody that specifically recognizes avian glial cells (Dulac et al., 1988) . Neurons were evidenced with a polyclonal antibody to the 200 x lo3 Mr form of neurofilament proteins (Amersham). Neurons and a subset of non-neuronal cells were immunostained with either one of the anti-p75 antisera described above (1:lOOO dilution). Both ~75 antibodies yielded identical staining patterns on fixed DRG cultures. The expression of BDNF immunoreactive protein was revealed in cultures of DRG freshly fixed either with 4% formaldehyde or with Bouin's fluid, using a specific polyclonal antibody against human recombinant BDNF. This antibody showed no crossreactivity with the related neurotrophins NT-3 and NGF (Dugich-Djordjevic et al., 1995; Goodman et al., 1996) but had no function-blocking activity (unpublished observations).
Total cells were visualized after staining with the Hoechst nuclear stain (Serva, 1 @g/ml).
In situ hybridization
In situ hybridization was performed according to a published protocol (Kahane and Kalcheim, 1994) using probes for the chicken neurotrophins BDNF and NT-3 whose cloning was previously described (Kahane et al., 1996) . These probes also hybridized efficiently with quail tissue.
Quantifzcation and data analysis
Quantification of the number of total cells, neurons, and SMP-immunoreactive non-neuronal cells was performed using a Zeiss Axioscope microscope equipped with epifluorescence and phase optics. In cultures of non-neuronal cells, the proportion of SMP+ glia was calculated as a function of total cells. Total non-neuronal cells include neural crest-derived satellite ganglionic cells and Schwann cells and their respective precursors, but also mesodermal fibroblasts. Of these cell categories, only the first three are potentially able to express SMP (Cameron-Curry et al., 1993) . In DRG cultures containing both neurons and non-neuronal cells, the percentage of SMP+ cells is given as a function of total number of non-neuronal cells (SMP-negative plus SMP-positive). Between 40 and 80 fields were scored per culture dish. Experiments were repeated between three and six times in triplicate cultures for each experimental condition.
The proliferation of SMP-positive non-neuronal cells was calculated as the percentage of cells with [3H]thymidine grains over nuclei. Results are expressed either as the average number of cells in a given number of microscopic fields (*SD of triplicate cultures), or as the average percentage of SMP+ non-neuronal cells or neurofilament + neurons (*SD of triplicate cultures). Significance of the results was examined using one-way analysis of variance (ANOVA). When significant differences were indicated in the F ratio test (P < O.OOS), the significance of differences between means of any two of these groups was determined using the modified Tukey method for multiple comparisons with an CY of 0.05.
